Functionally, the herein described TRIM25-dependent inhibition of caspase-2 could represent a so far unrecognized post-transcriptional survival mechanism utilized by colorectal carcinoma cells, and further supports the tumorigenic capacity of this particular TRIM member. The gene discussed is TRAT1; the disease is colorectal carcinoma.